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SUMMARY
Gasdermin D (GSDMD) is considered a proinflammatory factor that mediates pyroptosis in 
macrophages to protect hosts from intracellular bacteria. Here, we reveal that GSDMD deficiency 
paradoxically augmented host responses to extracellular Escherichia coli, mainly by delaying 
neutrophil death, which established GSDMD as a negative regulator of innate immunity. In 
contrast to its activation in macrophages, in which activated inflammatory caspases cleave 
GSDMD to produce an N-terminal fragment (GSDMD-cNT) to trigger pyroptosis, GSDMD 
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cleavage and activation in neutrophils was caspase independent. It was mediated by a neutrophil-
specific serine protease, neutrophil elastase (ELANE), released from cytoplasmic granules into the 
cytosol in aging neutrophils. ELANE-mediated GSDMD cleavage was upstream of the caspase 
cleavage site and produced a fully active ELANE-derived NT fragment (GSDMD-eNT) that 
induced lytic cell death as efficiently as GSDMD-cNT. Thus, GSDMD is pleiotropic, exerting both 
pro- and anti-inflammatory effects that make it a potential target for antibacterial and anti-
inflammatory therapies.
In Brief
Kambara et al. find that GSDMD deficiency augments host responses to extracellular Escherichia 
coli, mainly by delaying neutrophil death, establishing GSDMD as a negative regulator of innate 
immunity. GSDMD cleavage and activation in neutrophils is mediated by ELANE, released from 
cytoplasmic granules into the cytosol in aging neutrophils.
INTRODUCTION
Neutrophils are terminally differentiated cells and have a short lifespan in circulation and 
tissue (Lahoz-Beneytez et al., 2016; Lord et al., 2001). Neutrophil death plays a critical role 
in regulating neutrophil numbers in infection and inflammation. Aging neutrophils undergo 
programmed death and are then recognized, engulfed, and safely cleared by professional 
phagocytes such as macrophages (Savill et al., 1989). Neutrophil death shares many features 
of classical apoptosis and involves caspase activation. However, it is not entirely caspase 
dependent. Inhibition of caspases, which are critical mediators of apoptosis, delays but does 
not completely abolish cell death, suggesting that other mechanisms of neutrophil death 
exist Loison et al., 2014; Luo and Loison, 2008).
Gasdermin D (GSDMD) was recently identified as the factor responsible for the 
inflammatory form of lytic pyroptotic cell death, a critical antibacterial innate immune 
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defense mechanism (He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015a). Activated 
inflammatory caspases (caspase-1/4/5/11) cleave GSDMD in macrophages to produce an N-
terminal fragment (GSDMD-cNT) that triggers pyroptosis by binding to 
phosphatidylinositol phosphates and phosphatidylserine in the cell membrane inner leaflet to 
induce membrane pore formation and interleukin-1β (IL-1β) secretion (Aglietti et al., 2016; 
Chen et al., 2016; Ding al., 2016; He et al., 2015; Liu et al., 2016; Sborgi et al., 2016). 
GSDMD-cNT also binds to cardiolipin in the inner and outer leaflets of bacterial 
membranes, suggesting that it may directly kill bacteria by perforating bacterial membranes 
(Ding al., 2016; Liu et al., 2016). Based on these studies, GSDMD generally considered 
proinflammatory and an important host response to bacterial infection. Although GSDMD-
deficient mice are protected from lethal endotoxemia (Kayagaki et al., 2015; Shi et al., 
2015a), their bactericidal capability against extracellular pathogens has not been examined 
directly.
Here, we reveal that GSDMD deficiency unexpectedly and paradoxically augments host 
defenses against extracellular Escherichia coli by delaying neutrophil death. Its cleavage and 
activation in neutrophils is caspase independent, instead mediated by a neutrophil-specific 
serine protease, neutrophil elastase (ELANE), and released from neutrophil granules into the 
cytosol during neutrophil death. GSDMD controls neutrophil death and negatively regulates 
neutrophil-mediated innate immunity. Thus, GSDMD can exert context-dependent 
proinflammatory and anti-inflammatory effects and is a unique target for antibacterial and 
anti-inflammatory therapies.
RESULTS
GSDMD-Deficient Mice Display Augmented Bactericidal Activity against E. coli
Pyroptosis often occurs when macrophages are infected with intracellular pathogens and is 
thought to be critical for the clearance of these pathogens (Jorgensen and Miao, 2015; 
Jorgensen et al., 2016). Whether GSDMD contributes to the general bactericidal activity in 
host defense and the potential mechanism leading to its activation during this process 
remains elusive. We therefore explored bacterial killing in wild-type (WT) and GSDMD-
deficient mice (Figures S1A–S1E) in a murine acute peritoneal infection (peritonitis) model 
(Li et al., 2009). As previously reported, Gsdmd−/− mice were viable, fertile, and of normal 
size; peripheral blood differential counts were normal; and blood smears showed no 
hematopoietic abnormalities (Figures S1F–S1H). We then assessed the survival of WT and 
knockout (KO) mice in a lipopolysaccharide (LPS)-induced sepsis model. Consistent with 
the published results, our GSDMD-deficient mice also showed significantly improved 
survival compared to the WT mice (Figure S1I).
In this model, the host defenses suppress bacterial proliferation and gradually clear the 
intraperitoneally injected Gram-negative E. coli. 36 hr after injection of 5 × 107 live E. coli, 
the number of viable bacteria in peritoneal cavities consistently reduced to 2 × 104 in WT 
mice, reflecting a functioning immune system. Significantly fewer bacteria (1.8 × 103) were 
detected in inflamed GSDMD-deficient mice, suggesting that host responses to bacteria are 
enhanced in these mice (Figure 1A). Bacteria disseminate widely in infected hosts during 
severe infection, but, consistent with enhanced host immune responses in GSDMD-deficient 
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mice, bacterial loads also were significantly reduced in the spleens, livers, and kidneys of 
GSDMD-deficient mice compared to WT mice (Figure 1B). WT mice also displayed 
marked splenomegaly, another sign typical of bacterial infection (Figures S1J and S1K). 
Infection-associated splenomegaly was alleviated significantly in the GSDMD-deficient 
mice. Collectively, GSDMD disruption appears to augment host bactericidal activity to E. 
coli infection, indicating that GSDMD may be a negative regulator of innate immunity.
The Augmented Host Antibacterial Response in GSDMD-Deficient Mice Is the Result of 
Enhanced Neutrophil Accumulation
Enhanced bacterial killing may be the result of enhanced phagocytosis of bacteria by 
neutrophils. We first assessed neutrophil phagocytosis capability using mouse bone marrow 
neutrophils. GSDMD deficiency did not alter phagocytosis efficiency as measured by the 
percentage of neutrophils that engulfed at least one E. coli bioparticle (Figure 2A). The 
phagocytosis index of GSDMD-deficient neutrophils also was comparable to that of WT 
neutrophils: nearly 100 bacteria were engulfed by 100 neutrophils (Figure 2A). We next 
examined whether GSDMD disruption intrinsically alters the bactericidal capability of 
neutrophils in vitro using purified WT and GSDMD-deficient neutrophils, but GSDMD-
deficient neutrophils were equally as efficient as WT neutrophils at clearing live E. coli 
(Figure 2B). The intracellular bactericidal activity of neutrophils was further assessed by 
treating samples with a plasma membrane-impermeable antibiotic that kills extracellular 
bacteria but not internalized intracellular bacteria. The same number of viable engulfed 
bacteria was detected in both GSDMD-deficient and WT neutrophils, suggesting that 
GSDMD does not directly regulate the killing of intracellular bacteria (Figure 2B). Thus, the 
increased bactericidal activity observed in GSDMD-deficient mice does not appear to occur 
because the intrinsic bacterial killing capability of each neutrophil is enhanced. Similar 
results were observed when phagocytosis and bacterial killing capability were examined in 
peripheral blood neutrophils (Figures 2C and 2D).
Elevated bacterial killing also may be caused by enhanced neutrophil accumulation in the 
inflamed peritoneal cavity. Few peritoneal neutrophils were present in unchallenged mice; 
however, after E. coli injection, the number of peritoneal neutrophils increased to the same 
extent in both WT and GSDMD-deficient mice to nearly 9 × 106 after 24 hr (Figure 2E). 
GSDMD deficiency does not, therefore, affect initial neutrophil recruitment, but GSDMD-
deficient mice did show drastic increases in E. coli-induced neutrophil accumulation (15 × 
106 versus 7 × 106 neutrophils in Gsdmd−/− versus WT mice, respectively) 48 hr after E. coli 
injection (Figure 2E). Therefore, the augmented host antibacterial response in GSDMD-
deficient mice is likely to be the result of enhanced neutrophil accumulation in the inflamed 
peritoneal cavity rather than an enhanced intrinsic capacity of neutrophils to kill bacteria. 
Thus, under this condition, GSDMD acted as an anti-inflammatory factor. Consistently, the 
levels of proinflammatory cytokines in the peritoneal cavity were elevated significantly in 
Gsdmd−/− mice, suggesting that the production of these cytokines was not mediated mainly 
by macrophage pyroptosis (Figure 2F).
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Delayed Neutrophil Death Led to Elevated Neutrophil Accumulation and Enhanced Host 
Defenses in Gsdmd/Mice
Elevated neutrophil accumulation at sites of infection can occur simply as a result of 
enhanced neutrophil recruitment from the circulation to the inflamed peritoneal cavity, but 
the unaltered peritoneal neutrophil counts during the early stage of bacterial infection make 
this unlikely. In addition, we measured the peripheral neutrophil count before and after 
infection (Figure S2A). No difference was detected between the WT and GSDMD-deficient 
mice. In the bacterial peritonitis model, neutrophil recruitment can be regulated indirectly by 
the number of live bacteria remaining in the peritoneal cavity, which was reduced in 
GSDMD-deficient mice. Thus, to directly assess neutrophil recruitment during 
inflammation, we induced sterile peritonitis with thioglycolate (TG), which more rapidly 
elicited neutrophil recruitment than the bacterial model to reach a peak 7 hr after injection 
(Li et al., 2011). Again, similar numbers of peritoneal neutrophils were detected in WT and 
GSDMD-deficient mice at this early phase of inflammation, confirming that GSDMD 
deficiency does not alter neutrophil recruitment (Figures 3A and 3B). Furthermore, we 
measured the number of both resident and inflammatory macrophages in the peritoneal 
cavity. No difference was detected between the WT and GSDMD-deficient mice (Figure 
S2B). In addition, using an in vitro assay we examined the clearance of dead neutrophils by 
macrophages, a process known as efferocytosis (Poon et al., 2014). GSDMD disruption in 
macrophages did not affect efferocytosis efficiency (Figure S2C). We therefore speculated 
that the elevated neutrophil accumulation during late-stage infection was caused by a 
prolonged lifespan of recruited neutrophils.
We next explored whether neutrophil death is delayed in the peritoneal cavities of GSDMD-
deficient mice. We measured the percentage of dying neutrophils in peritoneal lavage fluid 
(PLF) by fluorescence-activated cell sorting (FACS) analysis (Figure 3C, S2D, and S3E). 
Although apoptotic neutrophils can be engulfed and cleared by macrophages, there were still 
>20% dying neutrophils (propidium iodide-positive [PI+] cells) in the inflamed peritoneal 
cavities of WT mice 48 hr after E. coli injection compared to only 8% dying neutrophils in 
GSDMD-deficient mice. Notably, the decrease of dying neutrophil number in GSDMD-
deficient mice was already detectable at 24 hr after E. coli injection before the total 
neutrophil number had started to decline (Figure 3D). Delayed neutrophil death may, 
therefore, be responsible for augmented neutrophil accumulation in GSDMD-deficient mice.
A reduction in dying peritoneal neutrophils could be the result of an altered peritoneal 
inflammatory environment, exaggerated clearance by peritoneal macrophages, or both. We 
next used a well-established in vitro system to determine whether delayed in vivo neutrophil 
death was indeed caused by alterations in intrinsic death/survival pathways in GSDMD-
deficient neutrophils (Xu et al., 2010) (Figure S3A). Neutrophils die even in the absence of 
any stimuli. Thus, this type of death also is called neutrophil spontaneous or constitutive 
death. We first explored whether neutrophil constitutive death is delayed in a GSDMD-
deficient neutrophil population. Freshly isolated GSDMD-deficient bone marrow or 
peripheral blood neutrophils were morphologically normal (Figure S3B). However, 
consistent with the in vivo results, in vitro-cultured GSDMD-deficient bone marrow 
neutrophils showed delayed spontaneous death compared to WT neutrophils, with 40% more 
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healthy neutrophils in the GSDMD-deficient neutrophil population compared to WT 
(Figures 3E and S3C). Similar results were observed in peripheral blood neutrophils (Figure 
3F). In the presence of E. coli, neutrophils die much faster.
We also examined the role of GSDMD in E. coli-induced neutrophil death, a process 
mediated mainly by phagocytosis. Again, we observed significantly delayed death in the 
GSDMD-deficient neutrophil population (Figures 3G, 3H, and S3D). Finally, we used an 
adoptive transfer assay to investigate whether GSDMD is involved intrinsically in neutrophil 
death in vivo (Figures 3I and 3J). In this assay, fluorescent-labeled WT and GSDMD-
deficient neutrophils were injected directly into the peritoneal cavity of the same recipient 
mice so that we were able to assess the survival and death of WT and GSDMD-deficient 
neutrophils in the same environment. Consistent with the ex vivo data, significantly more 
GSDMD-deficient neutrophils were detected in the inflamed peritoneal cavity compared to 
WT neutrophils 15 hr after the adoptive transfer (Figures 3I and 3J). The results of this 
experiment directly confirm that GSDMD disruption in neutrophils can intrinsically lead to 
delayed neutrophil death in vivo at the site of inflammation.
We also investigated whether GSDMD plays a role in neutrophil recruitment. Fluorescent-
labeled WT and GSDMD-deficient neutrophils were injected into an TG-challenged WT 
receipt intravenously. Peritoneal neutrophil number was assessed at earlier time points when 
neutrophil death had not yet occurred. The ratio of WT to GSDMD-deficient neutrophils in 
the inflamed peritoneal cavity remained unaltered compared to the input (1:1), indicating 
that disruption of GSDMD in neutrophils did not affect neutrophil recruitment during 
infection and inflammation (Figures S3E and S3F).
GSDMD Cleavage and Activation in Neutrophils Is Mediated by ELANE in a Caspase-
Independent Manner
Our results suggest that GSDMD may play a role in regulating neutrophil death. To further 
explore this hypothesis, we first investigated GSDMD expression in neutrophils. 
Examination of two publicly available transcriptomes of hematopoietic cells revealed that 
GSDMD is highly expressed in neutrophils at levels comparable to those in macrophages 
(Figures S4A and S4B). Consistent with this, GSDMD protein was present in both highly 
purified neutrophils and neutrophil-like differentiated HL60 cells (Figures 4A and 4B).
During macrophage pyroptosis, caspases cleave full-length GSDMD. To explore GSDMD 
cleavage activity in neutrophils, we incubated recombinant FLAG-tagged full-length 
GSDMD (FLAG-FL-GSDMD) with neutrophil lysate, thereby allowing us to track the 
cleaved NT GSDMD fragments. GSDMD could be processed by both human (Figure 4C) 
and mouse (Figure 4D) neutrophil lysates to generate an NT fragment of similar size to 
GSDMD-cNT. To investigate whether cleavage was caspase dependent, we included Z-Tyr-
Val-Ala-Asp(OMe)-fluoromethyl-ketone (z-YVAD-fmk), a caspase inhibitor, in the cleavage 
reaction. z-YVAD-fmk efficiently blocked caspase-elicited GSDMD cleavage as expected 
(Loison et al., 2014), but it failed to suppress human (Figure 4E) or mouse (Figure 4F) 
neutrophil lysate-elicited GSDMD cleavage, suggesting that GSDMD cleavage by 
neutrophil lysate was caspase independent. Noticeably, human neutrophil lysate degraded all 
of the GSDMD protein species. Compared to the input, there was virtually no human 
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GSDMD-NT (hGSDMD-NT) left after 30 min. Instead, the mouse lysate generated a stable 
mouse GSDMD-NT (mGSDMD-NT) fragment. The rapid degradation of hGSDMD-NT 
could be caused by other proteases in human neutrophil lysate. We wondered whether 
GSDMD was cleaved by neutrophil serine proteases to generate an active GSDMD-NT 
fragment. To test this, neutrophil lysates were treated with diisopropylfluorophosphate 
(DFP), a potent and irreversible serine protease inhibitor. DFP treatment significantly 
reduced both human and mouse neutrophil lysate-induced GSDMD cleavage (Figures 4E 
and 4F). Thus, GSDMD cleavage and activation in neutrophils is caspase independent and is 
likely to be mediated by a serine protease.
To determine which serine protease may be responsible for GSDMD cleavage and 
activation, we incubated FLAG-hGSDMD with caspase-1 and each of the three major 
neutrophil serine proteases: proteinase 3 (PR3), ELANE, and cathepsin G. As previously 
reported, caspase-1 cleaved FL-GSDMD to generate GSDMD-cNT. We were intrigued that 
one of the neutrophil serine proteases, ELANE, also cleaved GSDMD to generate a 
GSDMD-NT fragment (GSDMD-eNT) that was slightly smaller than GSDMD-cNT. In 
contrast, PR3 and cathepsin G failed to produce a significant number, if any, of GSDMD-NT 
fragments (Figure 4G). Several cleaved bands were detected by an antibody recognizing 
GSDMD, perhaps representing non-specific and non-functional cleavage in the middle of 
GSDMD (Figure S4C). The degree of GSDMD cleavage was positively correlated with 
ELANE enzymatic activity in the reaction (Figure S4D), and the cleavage was efficiently 
inhibited by ELANE-specific inhibitors sivelestat (Figure S4E), BAY-678 (Figure S4F), and 
GW311616A (Figure S4G) and by the pan-serine protease inhibitor DFP (Figure S4H). 
More important, GSDMD cleavage by whole human neutrophil lysate also was reduced 
significantly by ELANE-specific inhibitors in a dose-dependent manner (Figure 4H), and the 
GSDMD-NT fragment produced by neutrophil lysate was the same size as the one cleaved 
by ELANE (Figures S4I and S4J). Therefore, GSDMD cleavage activity in human 
neutrophil lysate appears to be attributable mainly to ELANE.
We next sought to investigate whether ELANE also mediates mGSDMD cleavage. Active 
recombinant mouse ELANE is not commercially available, so we incubated ELANE 
precursor with active cathepsin C/dipeptidylpeptidase I (DPPI), which removes dipeptide 
from the ELANE precursor to generate active mature ELANE (Adkison et al., 2002). In 
parallel to ELANE activation, mGSDMD was processed into two major NT fragments, one 
of which was a similar size to that of GSDMD-cNT (Figure 4I). ELANE-specific protease 
inhibitors inhibited generation of this fragment in a dose-dependent manner (Figure S4K), as 
did ELANE-deficient neutrophil lysate (Figure 4J). Thus, both mouse and human ELANE 
can effectively and efficiently cleave GSDMD to produce GSDMD-eNT in neutrophils. As a 
control, caspase-1/11 double KO (DKO) neutrophil lysate cleaved mGSDMD as efficiently 
as the WT neutrophil lysate, further indicating that GSDMD cleavage in neutrophils is 
caspase-1/11-independent (Figure 4K). Caspase-1/11 DKO mice consistently did not exhibit 
significantly elevated neutrophil accumulation in the peritonitis model, again confirming that 
the elevated neutrophil accumulation observed in the GSDMD-deficient KO is caspase-1/11 
independent (Figure 4L).
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Lysosomal Membrane Permeabilization Induces ELANE Release into the Cytosol, Leading 
to GSDMD Cleavage
GSDMD must co-localize with ELANE in neutrophils for cleavage, so we next examined 
this activity. In healthy neutrophils, the cytoplasmic granules mediate antimicrobial activity 
and contain all three serine proteinases, with the granule contents released during neutrophil 
death via lysosomal membrane permeabilization (LMP) (Figure 5A) (Loison et al., 2014). 
LMP was triggered in both spontaneous and E. coli-induced neutrophil death (Figures 5A 
and 5B). Cytosolic ELANE was consistently low in fresh healthy neutrophils and increased 
significantly during neutrophil death (Figures 5C and 5D), supporting a model in which 
LMP-induced ELANE release into the cytosol leads to GSDMD cleavage to facilitate 
neutrophil death. Indeed, we previously showed that the inhibition of LMP drastically delays 
constitutive neutrophil death (Loison et al., 2014). Consistent with our hypothesis, treatment 
with ELANE-specific inhibitor delayed significantly the death program in human 
neutrophils (Figure 5E). In addition, treatment with ELANE inhibitor could further promote 
the survival of neutrophils treated with the caspase-1/4/5-specific inhibitor, indicating that 
the effect of ELANE is independent of caspase-mediated GSDMD cleavage. Thus, ELANE 
appears to be a key regulatory protease that cleaves GSDMD to produce GSDMD-eNT 
during neutrophil death. Similar to what was observed in spontaneous neutrophil death, 
treatment with ELANE inhibitor also could promote the survival of cultured human 
neutrophils in the presence of E. coli infection (Figure 5F). It is noteworthy that ELANE 
inhibitor-induced suppression of neutrophil death was not as prominent as the one elicited 
by GSDMD disruption, indicating that ELANE may not be the only protease that cleaves 
and activates GSDMD in neutrophils. We next examined the bacterial killing capability of 
the untreated and ELANE inhibitor-treated neutrophil cultures (Figure 5G). ELANE 
inhibitor-induced delayed death of cultured human neutrophils led to augmented bacterial 
killing, consistent with the increased healthy neutrophil number in these cultures. We next 
assessed the neutrophil chemotaxis capability using a EZ-TAXIScan (ECI Frontier Inc) 
device (Hattori et al., 2010). It is interesting that the chemotaxis and phagocytosis 
capabilities of the surviving cells were unaltered (Figures S5A and S5B). This is consistent 
with the well-accepted mechanism by which GSDMD mediates cell death. The transiently 
generated GSDMD-NT triggers neutrophil death immediately upon its generation, leading to 
the attenuated overall bacterial killing capability of neutrophil culture. However, the 
surviving cells likely do not contain high levels of GSDMD-NT and thus function normally.
ELANE Cleaves GSDMD Upstream of the Caspase Cleavage Site to Generate a Smaller but 
Still Biologically Active GSDMD-eNT Fragment
GSDMD-eNT is slightly smaller than GSDMD-cNT on western blots. To determine the 
exact ELANE cutting site on GSDMD, we produced both human and mouse recombinant 
His-SUMO-GSDMD in E. coli, using the NT GSDMD-His-SUMO tag fusion to specifically 
purify GSDMD-eNT fragments after cleavage for subsequent mass spectrometry (MS) 
(Figure 6A). hGSDMD was incubated with ELANE or human neutrophil lysate, and intact 
and cleaved GSDMD bands were excised and subjected to liquid chromatography-MS 
(Figure 6B). Analysis of trypsin-digested fragments derived from FL-hGSDMD and 
hGSDMD-eNT localized the cleavage site to a seven-amino acid sequence between 268 and 
274 (Figure 6C). We then generated a series of hGSDMD deletion mutants between amino 
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acids 247 and 282. GSDMD-Δ268–274 and −Δ268–270 failed to be cleaved efficiently by 
ELANE, suggesting that the cleavage site localizes between C268 and H270 (Figure 6D). 
Because glycine is found rarely at ELANE cleavage sites and is thought to be an amino acid 
that cannot be cleaved by ELANE (Camper et al., 2016), we made glycine point mutants at 
268, 269, and 270. GSDMD-C268G but not other GSDMD mutants generated significantly 
less GSDMD-eNT in response to treatment with ELANE (Figure 6E), pinpointing the 
ELANE cleavage site on hGSDMD to C268 and further confirming by MS analysis AspN-
digested hGSDMD fragments. A peptide ending at C268 was identified in the GSDMD-eNT 
sample but not in the sample containing FL-hGSDMD (Figures 6F and 6G). The identified 
ELANE cleavage site, C268, was seven amino acids upstream of the caspase cleavage site 
D275 (Figure 6H). Using a similar approach, we revealed that mGSDMD was cleaved at 
V251 (Figures S6A– S6F). Notably, the GSDMD ELANE cleavage site was not well 
conserved between humans and mice (Figure S6G), suggesting that ELANE may recognize 
a tertiary structure rather than a particular amino acid sequence in GSDMD. These results 
are consistent with the known preference of ELANE for small hydrophobic amino acids 
such as Val, Cys, and Ala at the P1 position of protein substrates (Korkmaz et al., 2008).
The ELANE and caspase cleavage sites in GSDMD are, therefore, different. We next 
examined whether ELANE-mediated GSDMD cleavage also activates it by expressing 
human GSDMD-eNT (hGSDMD 1–268) and GSDMD-cNT (hGSDMD 1–275) in 293T 
cells (Figure 7A). GSDMD-NT-mediated plasma membrane pore formation depends on the 
oligomerization of GSDMD-NT molecules. Both hGSDMD-eNT and hGSDMD-cNT 
efficiently formed oligomers (Figure 7B) and localized to the plasma membrane (Figure 7C). 
Both hGSDMD-eNT and hGSDMD-cNT but not the FL or hGSDMD1 to 225, a truncated 
inactive form of hGSDMD, consistently induced lytic death of 293T cells (Figure 7D). The 
dying cells displayed typical lytic morphology of cell swelling and rupture and leakage of 
the plasma membrane, leading to intracellular DNA staining by membrane-impermeable PI 
(Movies S1, S2, S3, and S4). In addition, death-associated release of lactate dehydrogenase 
(LDH) also was comparable between hGSDMD-eNT- and hGSDMD-cNT-expressing cells 
(Figure 7E). Similar cytotoxicity also was observed when mGSDMD-eNTs (mGSDMD1–
251) were expressed in 293T cells (Figures S7A and S7B). Collectively, these results show 
that ELANE-cleaved GSDMD is biologically active and induces lytic cell death, which are 
consistent with previous findings that the minimum length of active GSDMD-NT is ~243 
amino acids (Shi et al., 2015a).
DISCUSSION
GSDM family proteins are inactive in their steady state because of autoinhibition by the C-
terminus domain (He et al., 2015; Shi et al., 2015a; Shi et al., 2015b). Their activation relies 
on cleavage of the FL protein to generate the NT active fragment. GSDM cleavage may be 
context dependent and mediated by distinct mechanisms in different tissues and cells. 
ELANE-meditated GSDMD cleavage is likely to be a specific GSDMD activation 
mechanism in neutrophils because other cell types, including monocyte-derived 
macrophages (MDMs), do not express ELANE (Figures S7C and S7D). Alternatively, 
ELANE may not be the only protease that cleaves and activates GSDMD in neutrophils. An 
NT fragment slightly larger than GSDMD-eNT was still generated in the absence of ELANE 
Kambara et al. Page 9
Cell Rep. Author manuscript; available in PMC 2018 March 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and also may participate in lytic cell death (Figure 4J). Inflammasome-mediated caspase-1 
activation has been implicated in neutrophil-mediated cytokine release and neutrophilic 
inflammation (Bakele et al., 2014; Chen et al., 2014; Karmakar et al., 2016), and thus may 
elicit GSDMD cleavage and activation in neutrophils independent of ELANE. Nevertheless, 
caspase-1/11 DKO neutrophil lysate cleaved mGSDMD as efficiently as the WT neutrophil 
lysate to generate mGSDMD-NT (Figure 4K). In addition, caspase-1/11 DKO mice did not 
exhibit elevated neutrophil accumulation in the peritonitis model, confirming that the 
elevated neutrophil accumulation observed in the GSDMD-deficient KO is caspase 
independent.
In macrophages, cleavage of GSDMD induces membrane pore formation and 
proinflammatory cytokine (e.g., IL-1β) secretion (Aglietti et al., 2016; Chen et al., 2016; 
Ding et al., 2016; He et al., 2015; Liu et al., 2016; Sborgi et al., 2016). GSDMD-cNT also 
binds to cardiolipin in the inner and outer leaflets of bacterial membranes, suggesting that it 
may directly kill bacteria by perforating bacterial membranes (Ding et al., 2016; Liu et al., 
2016). On the basis of these studies, GSDMD is generally considered proinflammatory and 
an important host response to bacterial infection (Kayagaki et al., 2015; Shi et al., 2015a). 
Here, we reveal that GSDMD deficiency unexpectedly and paradoxically augments host 
defense against extracellular E. coli by delaying neutrophil death. GSDMD controls 
neutrophil death and negatively regulates neutrophil-mediated innate immunity. Because the 
dead neutrophils are rapidly engulfed and cleared by macrophages, this process generally 
reduces neutrophil number and is mainly anti-inflammatory. The levels of proinflammatory 
cytokines in the peritoneal cavity were elevated significantly in GSDMD-deficient mice, 
suggesting that the production of these cytokines was not mediated mainly by GSDMD-
mediated macrophage pyroptosis. This further confirmed that in E. coli-induced peritonitis, 
GSDMD acted as an anti-inflammatory factor. Thus, GSDMD can exert context-dependent 
proinflammatory and anti-inflammatory effects, making it a unique target for antibacterial 
and anti-inflammatory therapies (Figure S7E). Although both our in vitro and in vivo data 
demonstrated directly that GSDMD in neutrophils can intrinsically regulate neutrophil death 
during infection and inflammation, we cannot completely exclude the contribution of other 
cell types in the regulation of neutrophil accumulation in GSDMD-deficient mice. It also is 
noteworthy that the effect of GSDMD disruption on neutrophil death was not as drastic as its 
effect on in vivo bacteria killing. It is likely that a modest difference in neutrophil death can 
upregulate inflammation, leading to more neutrophil recruitment and a log difference in 
bacterial clearance.
Our results support a model in which ELANE cleaves and activates GSDMD to perforate the 
plasma membrane and induce lytic cell death in neutrophils. It is noteworthy that depletion 
of GSDMD did not completely block lytic neutrophil death, suggesting that other parallel 
pathways exist to facilitate neutrophil death. In fact, the canonical caspase-3-mediated 
mechanism is well documented to regulate neutrophil death. Alternatively, other GSDM 
family proteins may be expressed in neutrophils and cleaved by neutrophil proteases to 
promote neutrophil death in the absence of GSDMD. Apoptosis has long been considered 
the primary mechanism of cell death for aging neutrophils, but inhibition of caspases, which 
are critical mediators of apoptosis, delay but do not completely abolish cell death, 
suggesting that other mechanisms of neutrophil death exist (Loison et al., 2014; Luo and 
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Loison, 2008). Our most recent study showed that neutrophil death consists of not only 
apoptosis but also a heterogeneous collection of different types of cell death (Kasorn et al., 
2009; Teng et al., 2017). Here, we show that GSDMD-mediated lytic cell death also 
contributes to neutrophil death.
Serine proteases, including ELANE, are stored mainly in azurophilic granules at 
concentrations exceeding 5 mM (Borregaard and Cowland, 1997). They are key components 
of the innate immune system and mediate pathogen clearance via multiple mechanisms, 
including direct suppression of pathogen proliferation and survival, production of 
antimicrobial peptides, deactivation of virulence factors, and generation of neutrophil 
extracellular traps (NETs) (Stapels et al., 2015; Tkalcevic et al., 2000). ELANE-mediated 
degradation of bacterial outer membrane protein A (OmpA) can kill bacteria directly 
(Belaaouaj et al., 2000). ELANE-deficient mice displayed impaired host defenses against 
Gram-negative bacterial sepsis (Belaaouaj et al., 1998). It is interesting that mice lacking 
both PR3 and ELANE have been linked to accumulation of anti-inflammatory progranulin 
(PGRN) and exaggerated inflammation, suggesting a cooperative interaction between serine 
proteases (Kessenbrock et al., 2008). Here, we discovered an alternative mechanism by 
which ELANE regulates innate immunity by promoting neutrophil death.
The present study further demonstrates the significance of LMP in promoting neutrophil 
death (Figure S7F). We previously showed that another serine protease, PR3, is released 
from granules into the cytosol via LMP in aging neutrophils to cleave and activate caspase-3 
to cause neutrophil death (Loison et al., 2014). Inhibition of LMP significantly curtails PR3 
release from neutrophil granules and consequently delays neutrophil death. Here, we show 
that ELANE and ELANE-mediated GSDMD cleavage are other key mechanisms that 
mediate LMP-elicited neutrophil death. Thus, LMP should be a legitimate target for 
regulating neutrophil death in infection and inflammation. The mechanism leading to LMP 
is still ill-defined. Reactive oxygen species (ROS) accumulate in aging neutrophils and 
mediate neutrophil death (Xu et al., 2013; Xu et al., 2010). ROS-induced lipid peroxidation 
may directly cause rupture of granule membranes and LMP. Electron microscopy 
examination reveals obvious granule membrane rupture in aging neutrophils (Loison et al., 
2014). A recent study showed that ELANE release during NETosis also is triggered by ROS 
(Metzler et al., 2014). In resting neutrophils, ELANE is localized on the azurophilic granule 
membrane and associated with a multiprotein complex known as azurosome. Upon 
stimulation, oxidative burst generates ROS that in turn triggers dissociation of ELANE from 
azurosome into the cytosol and the subsequent translocation to the nucleus. It would be 
intriguing to investigate whether this azurosome-mediated mechanism also plays a role in 
neutrophil death and whether the azurosome-mediated pathway and LMP can regulate each 
other.
EXPERIMENTAL PROCEDURES
Mice
Eight- to 12-week-old male mice were used in all of the experiments. Corresponding 
littermates were used as WT controls in all of the experiments performed with KO mice. The 
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Boston Children’s Hospital Animal Care and Use Committee approved and monitored all of 
the procedures involving mice.
Neutrophil Apoptosis in the Inflamed Peritoneal Cavity
Peritonitis was induced by intraperitoneally injection with 5 × 107 E. coli (strain K12 
BW25113) in PBS. At indicated times after injection, the mice were euthanized with CO2. 
Peritoneal exudate cells were then harvested by three successive washes with 10 mL Hank’s 
balanced salt solution (HBSS) containing 0.2% BSA and 20 mM EDTA. The cells were 
stained with annexin V (fluorescein isothiocyanate [FITC] labeled, Invitrogen) and PI, and 
cell death was then analyzed by FACS using a FACSCanto II flow cytometer (Becton 
Dickinson, San Jose, CA).
Statistics
Analysis of statistical significance for the indicated datasets was performed with the two-
tailed Student’s t test using GraphPad Prism 5 (GraphPad Software, La Jolla, CA). p values 
< 0.05 were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• GSDMD-deficient mice display augmented bactericidal activity against 
Escherichia coli
• GSDMD is a key regulator of neutrophil death
• Delayed neutrophil death leads to enhanced host defense in GSDMD-
deficient mice
• GSDMD cleavage in neutrophils is mediated by neutrophil elastase
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Figure 1. GSDMD-Deficient Mice Display Augmented Bactericidal Activity
(A) E. coli clearance in inflamed peritoneal cavities. Live bacteria were quantified as total 
colony-forming units (CFU) in peritoneal lavage fluid (PLF).
(B) Total CFUs in the indicated organs and peripheral blood 36 hr after E. coli challenge.
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Figure 2. The Augmented Host Antibacterial Response in GSDMD-Deficient Mice Is the Result 
of Enhanced Neutrophil Accumulation
(A) In vitro phagocytosis assay. More than 200 neutrophils were counted in each group.
(B) In vitro killing of E. coli by bone marrow neutrophils. In vitro bacterial killing 
capabilities were reflected by the decrease in CFUs. Intracellular bactericidal activity of 
neutrophils was assessed by treating samples with kanamycin to kill extracellular bacteria.
(C) Phagocytosis of E. coli bioparticles by peripheral blood neutrophils. Results are the 
means (±SDs) of three independent experiments.
(D) In vitro killing of E. coli by peripheral blood neutrophils. Results are the means (±SDs) 
of three independent experiments.
(E) Total peritoneal cell and peritoneal neutrophil numbers in E. coli-challenged mice. Data 
shown at each time point are means ± SDs of four mice.
(F) Chemokine and cytokine levels in peritoneal cavity.
Results are the means (±SDs) of three independent experiments. *p < 0.05 versus WT.
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Figure 3. Delayed Neutrophil Death Elevates Neutrophil Accumulation and Enhances the Host 
Defense Response in GSDMD-Deficient Mice
(A) Neutrophil recruitment during sterile inflammation. At the indicated times, TG-
challenged mice were killed and peritoneal lavage fluid collected for FACS. Shown are 
representative FACS plots depicting recruited peritoneal neutrophils.
(B) Total neutrophil content in the lavage fluid was calculated based on FACS analysis. Data 
shown at each time point are means ± SDs of three mice.
(C) Neutrophil death during E. coli-induced peritonitis. Peritoneal cells were collected 48 hr 
after E. coli injection and then analyzed by FACS. Shown are representative FACS plots 
depicting dying peritoneal neutrophils (P2). See also Figures S2D and S2E.
(D) The percentage of dying neutrophils in the lavage fluid was calculated based on FACS 
analysis. Data shown at each time point are means ± SDs of three mice.
(E) Death of in vitro cultured WT and GSDMD-deficient bone marrow neutrophils. Shown 
are the percentage and absolute number of healthy neutrophils in the culture at time points 
indicated. Data shown are means ± SDs of three mice. See also Figures S3A–S3D.
(F) Death of in vitro cultured WT and GSDMD-deficient peripheral blood neutrophils. All 
of the values represent means ± SDs of three separate experiments.
(G) Death of in vitro cultured WT and GSDMD-deficient bone marrow neutrophils in the 
presence of E. coli. Bone marrow neutrophils were cultured with E. coli (1:5 ratio) for 2 hr. 
Data shown are means ± SDs of three mice.
(H) Death of in vitro cultured WT and GSDMD-deficient peripheral blood neutrophils in the 
presence of E. coli. Data shown are means ± SDs of three mice.
(I) In vivo death of adoptively transferred neutrophils.
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(J) The ratios of adoptively transferred WT and GSDMD-deficient neutrophils. The input 
control was normalized to 1, and the results shown are the ratios at 15 hr after the adoptive 
transfer.
All of the values represent means ± SDs. *p < 0.05 versus WT.
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Figure 4. The Cleavage and Activation of GSDMD in Neutrophils Is Mediated by ELANE in a 
Caspase-Independent Manner
(A) GSDMD is highly expressed in neutrophils. GSDMD in human neutrophils and 
monocyte-derived macrophages (MDMs) was detected by western blotting with anti-
GSDMD antibody. The purity of highly purified neutrophils (HPNs) was confirmed by 
Wright-Giemsa staining of cytospin samples.
(B) GSDMD expression in undifferentiated and differentiated HL60 cells.
(C) Cleavage of human GSDMD (hGSDMD) by human neutrophil lysate. FLAG-hGSDMD 
was overexpressed in HEK293T cells. Cell lysates containing recombinant FLAG-hGSDMD 
were incubated with human neutrophil lysate for the times indicated. The positions of the 
full-length (FL-GSDMD) and ELANE-cleaved N-terminal hGSDMD (hGSDMD-NT) are 
indicated.
(D) Cleavage of mouse GSDMD (mGSDMD) by mouse neutrophil lysate. FLAG-
mGSDMD was overexpressed in HEK293T cells and was incubated with mouse neutrophil 
lysate for the times indicated.
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(E) hGSDMD cleavage by human neutrophil lysate was mediated by serine proteases. The 
cleavage of FLAG-hGSDMD by caspase-1 or human neutrophil lysate was conducted as 
described in Figure 4C in the presence of indicated inhibitors.
(F) The cleavage of mGSDMD by mouse neutrophil lysate in the presence of caspase or 
serine protease inhibitor.
(G) The cleavage of hGSDMD by serine proteases. FLAG-hGSDMD was overexpressed in 
HEK293T cells. Cell lysates containing recombinant FLAG-hGSDMD were incubated with 
human recombinant caspase 1 (100 units), PR3 (2 μg), ELANE (2 μg), or cathepsin G (2 μg) 
at 37°C for 30 min in a 6-well plate. The positions of the FL- and ELANE-cleaved 
hGSDMD are indicated.
(H) The cleavage of hGSDMD by human neutrophil lysate in the presence of the indicated 
number of ELANE-specific inhibitors.
(I) The cleavage of mGSDMD by mouse ELANE. FLAG-mGSDMD was overexpressed in 
HEK293T cells and incubated with the indicated proteases. ELANE enzymatic activity was 
determined using an ELANE-specific substrate following the manufacturer’s protocol.
(J) The cleavage of mGSDMD by ELANE-deficient neutrophil lysate. Disruption of 
ELANE was confirmed by western blotting with ELANE antibody.
(K) The cleavage of mGSDMD by caspase-1/11-deficient neutrophil lysate.
(L) Total peritoneal cell and peritoneal neutrophil numbers in E. coli-challenged WT and 
caspase-1/11-deficient mice. Total neutrophil content in the lavage fluid was calculated by 
FACS analysis.
Data shown at each time point are means ± SDs of four mice. NS, not significant; p > 0.05 
versus WT.
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Figure 5. Lysosomal Membrane Permeabilization Induces ELANE Release into the Cytosol and 
the Subsequent GSDMD Cleavage
(A) Neutrophil lysosomal membrane permeabilization (LMP) was assessed using the 
acridine orange (AO) uptake assay after 24 hr of culture. Shown are representative images 
and FACS plots of three independent experiments.
(B) E. coli-induced LMP. Mouse or human neutrophils were cultured with opsonized E. coli 
(1:5 ratio) for 30 min. Cells containing ≥5 granules and cells containing <5 granules are 
calculated. Shown are representative images of three independent experiments.
(C) PR3 and ELANE protein expression in whole-cell lysates (WCL) and the cytosolic 
fraction of fresh and aging neutrophils. Shown are representative blots of three independent 
experiments.
(D) PR3 and ELANE protein expression in neutrophils treated with E. coli. Human and 
mouse neutrophils were cultured with opsonized E. coli (1:5 ratio) for 60 min. Shown are 
representative blots of three independent experiments.
(E) Spontaneous neutrophil death in the presence of ELANE, caspase-1/4/5-specific 
inhibitors, or all of these. Human primary neutrophils were isolated and cultured in the 
presence of ELANE-specific inhibitor sivelestat (1 μg/mL), caspase-1/4/5-specific inhibitor 
z-WEHD-fmk (10 μM), or all of these for 26 hr. All of the values represent means ± SDs.
(F) E. coli-induced neutrophil death in the presence of ELANE inhibitor. Human neutrophils 
were cultured with opsonized E. coli (1:5 ratio) in the presence of sivelestat (1 μg/mL) for 
60 min. All of the values represent means ± SDs of three experiments.
(G) In vitro killing of E. coli by aged human neutrophils. Human primary neutrophils were 
isolated and cultured in the presence of ELANE-specific inhibitor sivelestat (1 μg/mL) for 
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26 hr. The cultured aged neutrophils were then incubated with E. coli for 1 hr. In vitro 
bacterial killing capabilities were reflected by the decrease in CFU after indicated incubation 
periods.
All of the values represent means ± SDs of three experiments. *p < 0.05 versus control.
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Figure 6. ELANE Cleaves GSDMD Upstream of the Caspase Cleavage Site
(A) Schematic ofGSDMD cleavage by ELANE and the strategy for identifying the cleavage 
site by mass spectrometry (MS).
(B) Recombinant human His-SUMO-GSDMD was incubated with ELANE or human 
neutrophil lysates at 37°C for 30 min and subjected to SDS-PAGE followed by colloidal 
blue staining. The FL and ELANE-cleaved GSDMD-NT fragment were trypsin digested and 
analyzed by MS.
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(C) Trypsin-digested peptides derived from the FL (blue lines) and ELANE-cleaved (red 
lines) GSDMD are underlined. The putative ELANE cleavage sites are highlighted.
(D) The cleavage of hGSDMD deletion mutants by ELANE. The FLAG-tagged hGSDMD 
deletion mutants were overexpressed in HEK293T cells. ELANE-mediated hGSDMD 
cleavage was carried out and analyzed as described in Figure 4C.
(E) The cleavage of hGSDMD point mutants by ELANE. Results are representative of four 
independent experiments.
(F) MS analysis of the ELANE cleavage site in hGSDMD was conducted using AspN-
digested samples. Top, mass spectrum of oxidized AspN-peptide generated through the 
cleavage. Bottom, MS/MS spectrum of the corresponding peptide showing the fragment ions 
detected and used for protein identification.
(G) MS analysis identifies C268 as the ELANE cleavage site in hGSDMD. AspN-digested 
peptides derived from the FL (blue lines) and ELANE-cleaved (red lines) GSDMD are 
underlined.
(H) ELANE- and caspase-1-cleaved hGSDMD at different sites.
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Figure 7. ELANE Cleaves GSDMD to Generate a Smaller but still Biologically Active GSDMD-
eNT Fragment
(A) Expression of FLAG-tagged FL, ELANE-cleaved (hGSDMD-eNT or 1–268), and 
caspase-cleaved (hGSDMD-cNT or 1–275) human GSDMD in HEK293T cells. The cells 
were lysed 24 hr post-transfection.
(B) GSDMD protein oligomerization. The cells expressing the indicated hGSDMD protein 
were lysed with lysis buffer with or without disuccinimidyl suberate crosslinking reagent (1 
mg/mL) and incubated at room temperature for 30 min. The reaction was quenched by 0.1 
M Tris, pH 7.4.
(C) Subcellular localization of recombinant hGSDMD in 293T cells. Shown are 
representative images of three independent experiments.
(D) Cell morphology of transfected cells was observed by bright field microscopy 24 hr 
post-transfection (see also Movies S1, S2, S3, and S4). PI staining was conducted to assess 
cell death. Shown are representative images of three independent experiments.
(E) Cytotoxicity was measured using a lactate dehydrogenase (LDH) cytotoxicity assay. All 
of the values represent means ± SDs of three independent experiments.
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